Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiovascular Ultrasound Systems Market

Cardiovascular Ultrasound Systems Market Trends

Report ID: GMI6064
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Cardiovascular Ultrasound Systems Market Trends

The rising incidence of cardiovascular diseases, including heart conditions, vascular disorders, and hypertension, is driving the demand for cardiovascular ultrasound systems. These systems play a crucial role in diagnosing, monitoring, and managing cardiovascular conditions. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally, accounting for an estimated 20.5 million deaths in 2021. Further, the incidence of cardiovascular diseases is increasing, partially due to factors such as sedentary lifestyles, unhealthy diets, tobacco use, obesity, and an increasing aging population base. This rise in incidence contributes to the growing demand for cardiovascular ultrasound systems for medical imaging purpose.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market for cardiovascular ultrasound systems was valued at USD 1.8 billion in 2022 and is projected to reach USD 3.1 billion by 2032, owing to technology advancements that enable improved imaging capabilities, increased efficiency, and enhanced diagnostic accuracy.

The doppler segment dominated the market in 2022 and will reach over USD 1.2 billion by 2032, as these systems offer a non-invasive method to assess blood flow in real-time, coupled with the cost-effective and safe imaging modality.

U.S. industry accounted for over USD 650 million in 2022 and is projected to grow in coming years attributable to rapid technological advancements, along with increasing number of cardiovascular diseases, such as heart disease and stroke.

GE Healthcare, Koninklijke Philips, Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Shenzhen Mindray Bio, Medical Electronics Co., Ltd. (Mindray), Health Catalyst (KPI Healthcare Inc.), and Fujifilm Sonosite, Inc. among others.